Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
January 24, 2005
- New Year's Gathering of 4 Tokyo-based Associations
January 24, 2005
- MEDICAL DEVICE NEWS IN BRIEF
January 24, 2005
- Leaders Outline Strategies for Survival in New Year's Addresses
January 24, 2005
- BULLETIN
January 24, 2005
- Aventis Pharma Aims to Strengthen Allegra's Leading Position
January 24, 2005
- BULLETIN
January 24, 2005
- Pfizer Strengthens Ties with Customers via Territory Management System
January 17, 2005
- MEDICAL DEVICE NEWS IN BRIEF
January 17, 2005
- BUSINESS NEWS IN BRIEF
January 17, 2005
- New Year's Commentary
January 17, 2005
- WEBSITE NEWS
January 17, 2005
- NEW PRODUCTS
January 17, 2005
- Details on Japan-US Regulatory Reform Initiative Revealed: Korosho
January 17, 2005
- Non-ICH Countries Interested in GCP, Pharmacovigilance: Yokohama Meeting
January 17, 2005
- Korosho's Budget for Science, Technology to Hold Firm at \129 Bil.
January 17, 2005
- Monkasho's Draft Budget Earmarks \81.8 Bil. for Life Science
January 17, 2005
- METI's Draft Budget Earmarks \3.55 Bil. for Service Industry Creation
January 17, 2005
- REGULATORY NEWS IN BRIEF
January 17, 2005
- Meet the Leaders (39)
January 17, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…